Who owns CHINOOK THERAPEUTICS INC.?
- Ticker: KDNY
- CUSIP Number: 16961l106
Tip: Access positions for across all investors
Analyze quarterly positions in Chinook Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Chinook Therapeutics stock
Who bought or sold CHINOOK THERAPEUTICS INC. this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
---|---|---|---|---|---|---|
Samsara BioCapital | 4.6M | $75M | 36% | Mar 2022 | ||
Baker Bros. Advisors | 2.3M | $38M | 23% | Mar 2022 | ||
Vanguard Group | 1.8M | $30M | 28% | Mar 2022 | ||
Dr. Jeffrey R. Jay, M.D. | 1.4M | $23M | 100% | Mar 2022 | ||
OrbiMed Advisors | 1.4M | $23M | 0% | Mar 2022 | ||
Octagon Capital Advisors | 1.4M | $22M | 100% | Mar 2022 | ||
VR Adviser | 1.3M | $21M | 100% | Mar 2022 | ||
Point72 Asset Management | 1.3M | $21M | -47% | Mar 2022 | ||
Suvretta Capital Management | 1.2M | $20M | 19% | Dec 2021 | ||
Candriam Luxembourg S.C.A. | 1.2M | $19M | 7% | Mar 2022 | ||
RA Capital Management | 1.0M | $16M | 100% | Mar 2022 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Chinook Therapeutics? |
||||||
TCG Crossover Management | 882k | $14M | 0% | Mar 2022 | ||
Vivo Capital | 872k | $14M | 0% | Mar 2022 | ||
Affinity Asset Advisors | 845k | $14M | 52% | Mar 2022 | ||
Baillie Gifford & Co | 811k | $13M | -4% | Mar 2022 | ||
Geode Capital Management | 777k | $13M | 6% | Mar 2022 | ||
Armistice Capital | 756k | $12M | -27% | Mar 2022 | ||
Laurion Capital Management | 755k | $12M | 100% | Mar 2022 | ||
Millennium Management | 737k | $12M | 11% | Mar 2022 | ||
FMR | 569k | $9.3M | -44% | Mar 2022 | ||
Rubric Capital Management | 564k | $9.2M | 0% | Mar 2022 | ||
Altium Capital Management | 545k | $8.9M | 0% | Mar 2022 | ||
Dimensional Fund Advisors | 521k | $8.5M | 78% | Mar 2022 | ||
Sphera Funds Management | 494k | $8.1M | 100% | Mar 2022 | ||
Northern Trust | 350k | $5.7M | 1% | Mar 2022 | ||
International Biotechnology Trust | 340k | $4.7M | 18% | Mar 2022 | ||
Renaissance Technologies | 267k | $4.4M | -28% | Mar 2022 | ||
Goldman Sachs Group | 235k | $3.8M | 8% | Mar 2022 | ||
Bank of America Corporation | 218k | $3.5M | 100% | Dec 2021 | ||
Nuveen Asset Management | 215k | $3.5M | 20% | Mar 2022 | ||
Ensign Peak Advisors | 186k | $3.0M | 81% | Dec 2021 | ||
Polar Securities | 182k | $3.0M | 100% | Mar 2022 | ||
Artal Group | 181k | $2.9M | 0% | Dec 2021 | ||
Walleye Trading Advisors | 174k | $2.8M | -2% | Mar 2022 | ||
Bank of New York Mellon | 153k | $2.5M | 8% | Mar 2022 | ||
Nicholas Investments Partners | 140k | $2.3M | 100% | Mar 2022 | ||
Morgan Stanley | 135k | $2.2M | 100% | Mar 2022 | ||
Jpmorgan Chase & Co | 133k | $2.2M | 2% | Mar 2022 | ||
Charles Schwab Investment Management | 112k | $1.8M | 9% | Mar 2022 | ||
Monashee Investment Management | 95k | $1.5M | 100% | Dec 2021 | ||
Pura Vida Investments | 85k | $1.4M | -6% | Mar 2022 | ||
Rafferty Asset Management | 79k | $1.3M | 100% | Mar 2022 | ||
D. E. Shaw & Co | 62k | $1.0M | -51% | Mar 2022 | ||
ALPS Advisors | 61k | $999k | 12% | Dec 2021 | ||
Citadel Advisors | 61k | $999k | 390% | Mar 2022 | ||
Citigroup | 60k | $976k | 100% | Dec 2021 | ||
Rhumbline Advisers | 46k | $747k | 12% | Dec 2021 | ||
State of Wisconsin Investment Board | 41k | $666k | 0% | Mar 2022 | ||
Marquette Asset Management | 36k | $581k | 85% | Mar 2022 | ||
Alliancebernstein | 34k | $553k | 7% | Mar 2022 | ||
Putnam Investments | 34k | $552k | 100% | Mar 2022 | ||
New York State Common Retirement Fund | 30k | $498k | 18% | Mar 2022 | ||
Martingale Asset Management | 28k | $457k | 119% | Dec 2021 | ||
Deutsche Bank Aktiengesellschaft | 21k | $348k | -10% | Mar 2022 | ||
Connor, Clark & Lunn Investment Management | 20k | $331k | 100% | Dec 2021 | ||
American International | 20k | $328k | -4% | Mar 2022 | ||
MetLife Investment Advisors | 20k | $325k | 58% | Mar 2022 | ||
Wells Fargo & Company | 17k | $282k | -68% | Dec 2021 | ||
California State Teachers Retirement System | 17k | $282k | -19% | Mar 2022 | ||
Manufacturers Life Insurance Company | 17k | $276k | -17% | Mar 2022 | ||
Russell Investments | 15k | $251k | -14% | Mar 2022 | ||
Axa | 13k | $216k | -44% | Mar 2022 | ||
ProShare Advisors | 13k | $214k | -18% | Mar 2022 | ||
Trexquant Investment | 12k | $203k | -58% | Mar 2022 | ||
DekaBank Deutsche Girozentrale | 11k | $186k | 10% | Mar 2022 | ||
Virtus ETF Advisers | 11k | $182k | -12% | Dec 2021 | ||
Quantbot Technologies | 5.0k | $81k | 117% | Dec 2021 | ||
Lazard Asset Management | 4.7k | $76k | 100% | Mar 2022 | ||
Summit Investment Advisors | 3.0k | $49k | 0% | Mar 2022 | ||
Metropolitan Life Insurance Company | 2.3k | $37k | -76% | Mar 2022 | ||
Zurcher Kantonalbank | 1.9k | $31k | 100% | Mar 2022 | ||
Simplex Trading | 1.8k | $29k | 100% | Mar 2022 | ||
Cubist Systematic Strategies | 1.7k | $27k | -97% | Mar 2022 | ||
CWM | 1.2k | $19k | 0% | Mar 2022 | ||
High Net Worth Advisory Group | 1.0k | $16k | 0% | Mar 2022 | ||
Aquatic Capital Management | 1.0k | $16k | 100% | Dec 2021 | ||
Advisor Group Holdings | 945.00 | $15k | 0% | Mar 2022 | ||
HighMark Wealth Management | 666.00 | $11k | 0% | Mar 2022 | ||
NISA Investment Advisors | 332.00 | $5.0k | -30% | Mar 2022 | ||
Daiwa Securities Group | 153.00 | $3.0k | 0% | Mar 2022 | ||
State of Wyoming | 151.00 | $2.0k | 48% | Mar 2022 | ||
Parallel Advisors | 5.00 | $0 | 0% | Mar 2022 |
Who sold out of Chinook Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Frazier Management | Dec 2021 | 2.4M | $39M |
Caas Capital Management | Sep 2021 | 61k | $775k |
ClariVest Asset Management | Sep 2021 | 54k | $684k |
William Blair $ Company | Sep 2021 | 22k | $276k |
Jump Financial | Sep 2021 | 17k | $217k |
Allspring Global Investments Holdings | Dec 2021 | 12k | $194k |
SG Americas Securities | Dec 2021 | 11k | $179k |
Squarepoint Ops | Dec 2021 | 11k | $177k |
Charter Oak Capital Management | Sep 2021 | 600.00 | $8.0k |